The largest database of trusted experimental protocols
> Anatomy > Body Location or Region > Hypopharynx

Hypopharynx

The hypopharynx is the lower part of the pharynx located behind the larynx.
It is a crucial structure for swallowing and speech.
Disorders affecting the hypopharynx can have significant impacts on an individual's health and quality of life.
Researchers studying the hypopharynx can leverage PubCompare.ai to streamline their work, locating relevant protocols from literature, pre-prints, and patents, and utilizing AI-driven comparisons to identify the best approaches.
This can enhance research reproducibility and efficiency, leading to advancements in understanding and treating hypopharynx-related conditions.

Most cited protocols related to «Hypopharynx»

The terminology recommended here encompasses major structural features of the body and all external characters recognized under light microscopy. Internal characters are not addressed herein, because the terminology in use is more consistent and uniform. We also exclude fine structural details, including those of peristomatic structures (epipharynx and hypopharynx), because they have been documented only recently, by histology and scanning electron microscopy, so that a consistent terminology is available (Edgecombe and Giribet 2006 ; Koch and Edgecombe 2006 , 2008 (link)). Our recommended terminology mainly focuses on adult morphology of extant chilopods, but is intended to be applicable to other post-embryonic stadia and to extinct taxa as well.
We considered all publications in English dealing with centipedes since Lewis’ (1981) treatise on chilopod biology (the most recent, comprehensive synthesis on the morphology of this group in English) and a selection of older works also in English (listed in the additional file: Pre-1981 publications) that seemed most relevant for the morphological terminology. We omitted XIX century publications, because their terminologies were often based on erroneous or unwarranted homologies with other arthropods and have long been superseded. We retrieved all applicable terms and assessed counterparts.
To maximize future applicability, alternative criteria of selection have been discussed with authors who are either currently the most active centipede systematists publishing descriptions in English and/or have already addressed issues of terminology standardization. In order to identify and recommend a single term for each character, we applied the following criteria: (i) we selected a term already used in the literature, except when all alternatives are either ambiguous or inconsistent with other selected terms; (ii) among alternatives, we selected either the term used most frequently (by most authors and/or in most publications) or the one explicitly introduced and defined by an influential author; (iii) we applied minor emendations to selected terms (in endings, prefixes, hyphenations between elements of compound words) when necessary for consistency and uniformity. We refrained from revising the terminology based on homology hypotheses with other arthropods (Edgecombe 2008 ), because many relationships remain under debate.PageBreak
Major anatomical differences exist between the six centipede orders, five extant - Scutigeromorpha, Lithobiomorpha, Craterostigmomorpha, Scolopendromorpha, and Geophilomorpha - and one extinct, Devonobiomorpha. Morphological and taxonomical investigations by different authors have sometimes been and still are limited to single orders, leading to different terminological traditions. While we propose a consistent terminology for the entire class, we specify the order(s) to which each term is applicable to facilitate usage by students interested in single orders; when no orders are specified, it is meant that the term is applicable to all orders; when an order is specified, it is meant that the term is applicable to at least some taxa in the order.
Full text: Click here
Publication 2010
Adult Anabolism Arthropods Character Chilopoda Embryo Extinction, Psychological Geophilomorpha Human Body Hypopharynx Light Microscopy Nasopharynx Scanning Electron Microscopy Student
A panel of 122 human head and neck cell lines was assembled from a number of different researchers, institutions, and suppliers. This panel was chosen to represent each of the major HNSCC sites: oral cavity, oropharynx, hypopharynx, and larynx. Also chosen for study were anaplastic and papillary thyroid cancer, adenoid cystic carcinoma cell lines, and cell lines derived from lymph node metastases. In some cases isogenic cell line pairs were obtained, which included cells derived from both the primary tumor and lymph node metastases from the same patient. Also included were cell lines from cutaneous SCC, leukoplakia, immortalized primary keratinocytes, and normal epithelium.
Publication 2011
Adenoid Cystic Carcinoma Anaplasia Cell Lines Cells Epithelium Head Homo sapiens Hypopharynx Keratinocyte Larynx Leukoplakia Lymph Node Metastasis Neck Neoplasms Oral Cavity Oropharynxs Papillary Thyroid Carcinoma Patients Skin Squamous Cell Carcinoma of the Head and Neck
The RTOG 0129 study was registered with the National Cancer Institute and approved by the institutional review boards at the participating centers. All patients provided written informed consent. The authors attest to the fidelity of the article to the full protocol and statistical-analysis plan.
Eligibility criteria were the presence of untreated, pathologically confirmed, stage III or IV squamous-cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx without distant metastases (M0)7 ; Zubrod’s performance status score of 0 or 1 (asymptomatic or symptomatic but ambulatory, respectively)8 (link); age of 18 years or older; and adequate bone marrow, hepatic, and renal function. Lifetime tobacco exposure was determined at enrollment with the use of a standardized, self-administered questionnaire.
Patients were stratified on the basis of the tumor site (larynx vs. other), nodal stage (N0 vs. N1, N2a, or N2b vs. N2c or N3), and Zubrod’s performance status score (0 vs. 1) and were randomly assigned to receive high-dose cisplatin concurrently with either accelerated-fractionation radiotherapy (with the acceleration provided by means of concomitant boost radiotherapy) or standard-fractionation radiotherapy. The accelerated-fractionation radiotherapy consisted of the delivery of 72 Gy in 42 fractions over a 6-week period, with a concomitant boost of twice-daily irradiation for 12 treatment days (as previously reported9 (link)), and standard-fractionation radiotherapy consisted of the delivery of 70 Gy in 35 fractions (i.e., 2 Gy per fraction) over a 7-week period. Intravenous cisplatin was administered at a dose of 100 mg per square meter of body-surface area on days 1 and 22 in the accelerated-fractionation radiotherapy group and on days 1, 22, and 43 in the standard-fractionation radiotherapy group.
Acute toxicity was evaluated weekly during the period of therapy according to the Common Terminology Criteria, version 2.0 (http://ctep.info.nih.gov/protocolDevelopment/electronic_applications/docs/ctcv20_4-30-992.pdf). To assess tumor status and late toxicity, according to RTOG criteria,10 (link) physical examinations and imaging studies were performed every 3 months for the first 2 years, every 6 months during years 3 through 5, and annually thereafter.
Publication 2010
Acceleration Body Surface Area Bone Marrow Cisplatin Eligibility Determination Ethics Committees, Research Hypopharynx Kidney Larynx Neoplasm Metastasis Neoplasms Obstetric Delivery Oropharynxs Patients Physical Examination Radiotherapy Radiotherapy Dose Fractionations Squamous Cell Carcinoma of the Mouth Therapeutics Tobacco Products
The study population comprised 6,034 cases and 6,585 controls derived
from 12 epidemiological studies, the majority of case-control design and part of
the International Head and Neck Cancer Epidemiology Consortium (INHANCE).
Additionally, cases and controls from a European cohort study (EPIC) and cases
from a United Kingdom case-series (HN5000) were also included. Characteristics
and references for each study are summarized in Supplementary Table 1.
Informed consent was obtained for all participants and studies were approved by
respective Institutions Review Boards. Cancer cases comprised the following ICD
codes: oral cavity (C02.0-C02.9, C03.0-C03.9, C04.0-C04.9, C05.0-C06.9)
oropharynx (C01.9, C02.4, C09.0-C10.9), hypopharynx (C13.0-C13.9), overlapping
(C14 and combination of other sites) and 25 oral or pharyngeal cases with
unknown ICD code (other).
Genomic DNA isolated from blood or buccal cells was genotyped at the
Center for Inherited Disease Research (CIDR) with a novel genotyping tool, the
Illumina OncoArray custom designed for cancer studies by the OncoArray
Consortium33 (link) part of the Genetic
Associations and Mechanisms in Oncology (GAME-ON) Network. The majority of the
samples were genotyped as part of the oral and pharynx cancer OncoArray, with
the exception of 2,476 shared controls (1,453 from the EPIC study and 1,023 from
the Toronto study) that were genotyped at CIDR but as part of the Lung
OncoArray. Genotype calls were made by the Dartmouth team in GenomeStudio
software (Illumina, Inc.) using a standardized cluster file for OncoArray
studies. Cluster plots for top SNPs for individuals genotyped as part the oral
and pharynx cancer OncoArray are shown in Supplementary Figure
12
.
Publication 2016
Blood Cancer of Head and Neck Cancer of Pharynx Cells Europeans Genome Hereditary Diseases Hypopharynx Malignant Neoplasms Neoplasms Oral Cavity Oropharynxs Pharynx Single Nucleotide Polymorphism
The study population comprised 6,034 cases and 6,585 controls derived
from 12 epidemiological studies, the majority of case-control design and part of
the International Head and Neck Cancer Epidemiology Consortium (INHANCE).
Additionally, cases and controls from a European cohort study (EPIC) and cases
from a United Kingdom case-series (HN5000) were also included. Characteristics
and references for each study are summarized in Supplementary Table 1.
Informed consent was obtained for all participants and studies were approved by
respective Institutions Review Boards. Cancer cases comprised the following ICD
codes: oral cavity (C02.0-C02.9, C03.0-C03.9, C04.0-C04.9, C05.0-C06.9)
oropharynx (C01.9, C02.4, C09.0-C10.9), hypopharynx (C13.0-C13.9), overlapping
(C14 and combination of other sites) and 25 oral or pharyngeal cases with
unknown ICD code (other).
Genomic DNA isolated from blood or buccal cells was genotyped at the
Center for Inherited Disease Research (CIDR) with a novel genotyping tool, the
Illumina OncoArray custom designed for cancer studies by the OncoArray
Consortium33 (link) part of the Genetic
Associations and Mechanisms in Oncology (GAME-ON) Network. The majority of the
samples were genotyped as part of the oral and pharynx cancer OncoArray, with
the exception of 2,476 shared controls (1,453 from the EPIC study and 1,023 from
the Toronto study) that were genotyped at CIDR but as part of the Lung
OncoArray. Genotype calls were made by the Dartmouth team in GenomeStudio
software (Illumina, Inc.) using a standardized cluster file for OncoArray
studies. Cluster plots for top SNPs for individuals genotyped as part the oral
and pharynx cancer OncoArray are shown in Supplementary Figure
12
.
Publication 2016
Blood Cancer of Head and Neck Cancer of Pharynx Cells Europeans Genome Hereditary Diseases Hypopharynx Malignant Neoplasms Neoplasms Oral Cavity Oropharynxs Pharynx Single Nucleotide Polymorphism

Most recents protocols related to «Hypopharynx»

Eligibility criteria are described in Table 1. The ORGAVADS study focuses on patients with surgically resectable HNSCC who undergo surgery at François Baclesse Center and Caen University Hospital Center. After patient screening according to criteria, and the patient’s non-opposition, the patient will be enrolled in the study. An identification number will be thus assigned to each patient to be used throughout the study.

ORGAVADS study inclusion and exclusion criteria

Inclusion criteriaNon-inclusion criteria
Patient  ≥ 18 yearsPregnant women
Histologically confirmed squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx or larynxPatient deprived of liberty or placed under the authority of a tutor
Patients for whom oncologic surgery is planned or who have recently undergone surgery of the tumor of oral cavity, oropharynx, hypopharynx or larynx
Subject affiliated to a social security regimen
No opposition to participate to the study
Full text: Click here
Publication 2023
Eligibility Determination Hypopharynx Mouth Neoplasms Operative Surgical Procedures Oropharynxs Patients Squamous Cell Carcinoma of the Head and Neck Squamous Cell Carcinoma of the Mouth
Incident cancer cases were identified through data linkage to national cancer and mortality registries, provided by the National Health Service (NHS) Digital for participants in England and Wales, and NHS Central Register for participants in Scotland.16 Cancer registries were coded in the 10th revision of the International Classification of Diseases (ICD-10) and the third edition of ICD for Oncology (ICD-O-3) morphology codes where appropriate, and were available up to 31 July 2019 for England and Wales, and 31 October 2015 for Scotland. Mortality registries were coded using ICD-10 and available up to 31 January 2021. Cancer deaths were defined as primary/underlying cause of death. We examined all cancers (C00–C97, except for non-melanoma skin cancer C44) and 34 site-specific cancers. Detailed list, coding and case numbers for each site-specific cancer are presented in Appendix Table S1 for cancer incidence and Appendix Table S2 for cancer mortality. Cancers with small case numbers (n < 40, e.g. hypopharynx, larynx) are presented but excluded from subsequent analyses.
Full text: Click here
Publication 2023
Cancer, Appendiceal Familial Atypical Mole-Malignant Melanoma Syndrome Health Services, National Hypopharynx Larynx Malignant Neoplasms Neoplasms
Human HNSCC cell lines utilized in this study included: Cal-33 (tongue SCC, Cellosaurus, accession number; CVCL_1108), FaDu (hypopharynx SCC, ATCC, accession number; HTB_43), HSC2 (oral cavity SCC, Cellosaurus, accession number; CVCL_1287), HSC3 (oral cavity SCC, Cellosaurus, accession number; CVCL_1288), KYSE 70 (esophageal SCC, Cellosaurus, accession number; CVCL_1356), KYSE 180 (esophageal SCC, Cellosaurus, accession number; CVCL_1349), and LB771 (head and neck SCC, Cellosaurus, accession number; CVCL_1369). All cell lines were maintained in a humidified atmosphere of 5% CO2 in air at 37 °C incubator in the appropriate cell culture media that was supplemented with 10% heat-inactivated fetal calf serum, 2 mML-glutamine, penicillin (100 U/mL), and streptomycin (100 μg/mL).
Full text: Click here
Publication 2023
Atmosphere Cell Culture Techniques Cell Lines Cells Culture Media Esophageal Squamous Cell Carcinoma Fetal Bovine Serum Glutamine Head Homo sapiens Hypopharynx Neck Penicillins Squamous Cell Carcinoma of the Head and Neck Squamous Cell Carcinoma of the Mouth Streptomycin Tongue
Analyzation was conducted with a 0.3 mm thickness of Raw-Dicom file, and OnDemand 3D (Cyber Med., Seoul, Republic of Korea) was used to analyze three-dimensionally. The analyzation was conducted by only one person to eliminate measurement errors and collected information was analyzed by OnDemand 3D that was used to measure the volume of airway at T0, T1, and T2.
To measure the volume of the airway space, it was measured in 3 different ways as follows:

Oropharyngeal airway space: the space was defined from the line which was passing through the posterior nasal spine and parallel to the FH plane to the end of the epiglottis, generally the most inferior portion of the soft palate.

Hypopharyngeal airway space: the space was defined below the oropharyngeal airway space and up to the line which was passing through the epiglottis and parallel to the FH plane, generally at the level of the end of the 3rd cervical vertebra.

Total airway was the sum of oropharyngeal airway space and hypopharyngeal airway space.

For easier understanding in this study, oropharyngeal airway space was renamed as “Airway 1” and hypopharyngeal airway space was renamed as “Airway 2” (Figure 2 and Figure 3).
Full text: Click here
Publication 2023
Cervical Vertebrae Epiglottis Hypopharynx Nose Oropharynxs Palate, Soft Tidal Volume Vertebral Column
Patients were divided into two groups based on the type of surgery: primary TL group and salvage TL group. Each patient’s clinical characteristics (gender, age, tumor site, T- and N-stage, etc.) of these two groups of patients were compared using Chi-square tests.
We analyzed the impact on OS, CSS and RFS of the type of surgery (primary vs. salvage TL) and of the following factors: age (< vs. >70 years), gender (male vs. female), ASA score (< vs. ≥3), primary tumor site (larynx vs. hypopharynx), preoperative tracheostomy, surgical margins (negative vs. positive), T-stage (3 vs. 4) and N-stage (< vs. ≥2A). Univariate analyses were performed using Log Rank tests. For multivariate analysis (conducted only when more than one factor was significant in univariate analyses), all variables associated with p < 0.05 in univariate analysis were included in Cox regression models with forward stepwise selection. The predictive ability of each Cox regression model was determined using the area under the receiver operating characteristic (ROC) curve (AUC) with a clinical endpoint fixed at 5 years.
All statistical analyses were performed at 5% alpha risk or 95% confidence interval by the biostatistician using R.3.0.1 software on Windows.
Full text: Click here
Publication 2023
Gender Hypopharynx Larynx Males Neoplasms Operative Surgical Procedures Patients Surgical Margins Tracheostomy Woman

Top products related to «Hypopharynx»

Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in United States
Circumferential pressure sensors are a type of laboratory equipment used to measure and record the changes in pressure around a specific area or circumference. These sensors are designed to provide accurate and reliable data on pressure variations within a controlled environment or during experimental procedures.
Sourced in United States, China, United Kingdom, Germany, France, Australia, Canada, Japan, Italy, Switzerland, Belgium, Austria, Spain, Israel, New Zealand, Ireland, Denmark, India, Poland, Sweden, Argentina, Netherlands, Brazil, Macao, Singapore, Sao Tome and Principe, Cameroon, Hong Kong, Portugal, Morocco, Hungary, Finland, Puerto Rico, Holy See (Vatican City State), Gabon, Bulgaria, Norway, Jamaica
DMEM (Dulbecco's Modified Eagle's Medium) is a cell culture medium formulated to support the growth and maintenance of a variety of cell types, including mammalian cells. It provides essential nutrients, amino acids, vitamins, and other components necessary for cell proliferation and survival in an in vitro environment.
Sourced in United States, Germany, United Kingdom, China, Canada, France, Japan, Australia, Switzerland, Israel, Italy, Belgium, Austria, Spain, Gabon, Ireland, New Zealand, Sweden, Netherlands, Denmark, Brazil, Macao, India, Singapore, Poland, Argentina, Cameroon, Uruguay, Morocco, Panama, Colombia, Holy See (Vatican City State), Hungary, Norway, Portugal, Mexico, Thailand, Palestine, State of, Finland, Moldova, Republic of, Jamaica, Czechia
Penicillin/streptomycin is a commonly used antibiotic solution for cell culture applications. It contains a combination of penicillin and streptomycin, which are broad-spectrum antibiotics that inhibit the growth of both Gram-positive and Gram-negative bacteria.
Sourced in United States, United Kingdom, Germany, China, France, Canada, Japan, Australia, Switzerland, Italy, Israel, Belgium, Austria, Spain, Brazil, Netherlands, Gabon, Denmark, Poland, Ireland, New Zealand, Sweden, Argentina, India, Macao, Uruguay, Portugal, Holy See (Vatican City State), Czechia, Singapore, Panama, Thailand, Moldova, Republic of, Finland, Morocco
Penicillin is a type of antibiotic used in laboratory settings. It is a broad-spectrum antimicrobial agent effective against a variety of bacteria. Penicillin functions by disrupting the bacterial cell wall, leading to cell death.
Sourced in United States, China, Germany, United Kingdom, Japan, France, Canada, Australia, Italy, Switzerland, Belgium, New Zealand, Spain, Israel, Sweden, Denmark, Macao, Brazil, Ireland, India, Austria, Netherlands, Holy See (Vatican City State), Poland, Norway, Cameroon, Hong Kong, Morocco, Singapore, Thailand, Argentina, Taiwan, Province of China, Palestine, State of, Finland, Colombia, United Arab Emirates
RPMI 1640 medium is a commonly used cell culture medium developed at Roswell Park Memorial Institute. It is a balanced salt solution that provides essential nutrients, vitamins, and amino acids to support the growth and maintenance of a variety of cell types in vitro.
Sourced in United States, United Kingdom, Germany, China, France, Canada, Australia, Japan, Switzerland, Italy, Belgium, Israel, Austria, Spain, Netherlands, Poland, Brazil, Denmark, Argentina, Sweden, New Zealand, Ireland, India, Gabon, Macao, Portugal, Czechia, Singapore, Norway, Thailand, Uruguay, Moldova, Republic of, Finland, Panama
Streptomycin is a broad-spectrum antibiotic used in laboratory settings. It functions as a protein synthesis inhibitor, targeting the 30S subunit of bacterial ribosomes, which plays a crucial role in the translation of genetic information into proteins. Streptomycin is commonly used in microbiological research and applications that require selective inhibition of bacterial growth.
Sourced in United States, China
The CAL27 is a cell line derived from a human squamous cell carcinoma of the tongue. It is a commonly used in vitro model for oral cancer research.
Sourced in United States
Human Hypopharyngeal Normal Cell Culture Media with Serum is a cell culture media formulation designed to support the growth and maintenance of human hypopharyngeal normal cells in vitro. This media contains the necessary growth factors, nutrients, and serum components required for the optimal proliferation and survival of these specific cell types.
Sourced in Japan
The HSC-4 is a laboratory equipment designed for the cultivation and storage of hematopoietic stem cells (HSCs). It provides a controlled environment for the propagation and preservation of these specialized cells. The core function of the HSC-4 is to enable the maintenance and expansion of HSCs in a laboratory setting.

More about "Hypopharynx"

The hypopharynx is the lower portion of the pharynx, situated behind the larynx.
This critical structure plays a crucial role in swallowing and speech.
Disorders affecting the hypopharynx can significantly impact an individual's health and quality of life.
Researchers studying the hypopharynx can leverage PubCompare.ai, an AI-driven platform, to streamline their work.
PubCompare.ai helps researchers locate relevant protocols from literature, pre-prints, and patents, and utilize AI-driven comparisons to identify the best approaches.
This can enhance research reproducibility and efficiency, leading to advancements in understanding and treating hypopharynx-related conditions.
Researchers can explore various cell culture media and techniques to study the hypopharynx.
FBS (Fetal Bovine Serum), a common supplement, can be used in cell culture media like DMEM (Dulbecco's Modified Eagle Medium) and RPMI 1640 medium to support cell growth and proliferation.
Penicillin and streptomycin are often added to these media to prevent bacterial contamination.
Cell lines like CAL27 and HSC-4 are commonly used in hypopharynx research.
By leveraging PubCompare.ai, researchers can streamline their hypopharynx studies, enhance reproducibility, and drive progress in understanding and treating conditions related to this critical anatomical structure.
The platform's AI-driven comparisons and protocol identification capabilities can significantly improve research efficiency and lead to meaningful advancements in the field.